Personal information

No personal information available

Activities

Collapse all

Works (8)

Dose Escalation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Short-Term Efficacy and Toxicity of VMAT–SIB vs. 3D-CRT

Medicina
2025-03-11 | Journal article
DOI: 10.3390/medicina61030483
Contributors: Suzana Stojanovic-Rundic; Mladen Marinkovic; Aleksandra Stanojevic; Dusica Gavrilovic; Radmila Jankovic; Natasa Maksimovic; Aleksandar Tomasevic; Predrag Petrasinovic; Sandra Radenkovic; Milena Cavic
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Dose Escalation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Efficacy and Toxicity of VMAT-SIB vs. 3D-CRT

2025-02-03 | Preprint
DOI: 10.20944/preprints202502.0071.v1
Contributors: Suzana Stojanovic-Rundic; Mladen Marinkovic; Aleksandra Stanojevic; Dusica Gavrilovic; Radmila Jankovic; Natasa Maksimovic; Aleksandar Tomasevic; Predrag Petrasinovic; Sandra Radenkovic; Milena Cavic
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Performance and Dimensionality of Pretreatment MRI Radiomics in Rectal Carcinoma Chemoradiotherapy Prediction

Journal of Clinical Medicine
2024-01-12 | Journal article
DOI: 10.3390/jcm13020421
Contributors: Mladen Marinkovic; Suzana Stojanovic-Rundic; Aleksandra Stanojevic; Aleksandar Tomasevic; Radmila Jankovic; Jerome Zoidakis; Sergi Castellví-Bel; Remond J. A. Fijneman; Milena Cavic; Marko Radulovic
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia

Translational Oncology
2023-11 | Journal article
DOI: 10.1016/j.tranon.2023.101772
Contributors: Miodrag Vukovic; Miljana Tanic; Ana Damjanovic; Marijana Pavlovic; Aleksandra Stanojevic; Katarina Zivic; Valentina Karadzic; Radmila Jankovic; Milena Cavic
Source: check_circle
Crossref

Methylenetetrahydrofolate reductase polymorphic variants in rectal cancer: significance for cancer risk and response to chemoradiotherapy

2023-09-23 | Preprint
DOI: 10.1101/2023.09.21.23295916
Contributors: Aleksandra Stanojevic; Jelena Spasic; Mladen Marinkovic; Suzana Stojanovic-Rundic; Radmila Jankovic; Ana Djuric; Jerome Zoidakis; Remond J.A. Fijneman; Sergi Castellvi-Bel; Milena Cavic
Source: check_circle
Crossref

Exploring novel inflammation-related genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer

2023-06-22 | Preprint
DOI: 10.1101/2023.06.20.23291673
Contributors: Mladen Marinkovic; Suzana Stojanovic-Rundic; Aleksandra Stanojevic; Marija Ostojic; Dusica Gavrilovic; Radmila Jankovic; Natasa Maksimovic; Rafael Stroggilos; Jerome Zoidakis; Sergi Castellví-Bel et al.
Source: check_circle
Crossref

Data independent acquisition mass spectrometry (DIA-MS) analysis of FFPE rectal cancer samples offers in depth proteomics characterization of response to neoadjuvant chemoradiotherapy

2023-05-16 | Preprint
DOI: 10.1101/2023.05.12.23289671
Contributors: Aleksandra Stanojevic; Martina Samiotaki; Vasiliki Lygirou; Mladen Marinkovic; Vladimir Nikolic; Suzana Stojanovic-Rundic; Radmila Jankovic; Antonia Vlahou; George Panayotou; Remond J.A. Fijneman et al.
Source: check_circle
Crossref

Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals

Expert Review of Molecular Diagnostics
2021-01-02 | Journal article
DOI: 10.1080/14737159.2021.1860760
Contributors: Milena Cavic; Ana Krivokuca; Ivana Boljevic; Jelena Spasic; Milica Mihajlovic; Marijana Pavlovic; Ana Damjanovic; Davorin Radosavljevic; Radmila Jankovic
Source: check_circle
Crossref
How many people are using ORCID?